NASDAQ
Intensity Therapeutics, Inc. (INTS) has a free cash flow growth of 23.95% as of Friday, May 29, 2026. This represents a 2184.29% increase compared to its 12-month average of 1.05%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.